Evidence map›Paper›PMID 39038747›Full record

ArticleAnnals of epidemiology2024

The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis.

Kristin R V Harrington, Neel R Gandhi, N Sarita Shah, Kogieleum Naidoo, Sara C Auld, Jason R Andrews, James C M Brust, Keeren Lutchminarain, Megan Coe, Fay Willis and 5 more

Abstract read
In one paragraph

Article in Annals of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Role of casual contact in drug-resistant tuberculosis transmission: a molecular epidemiology study.American journal of respiratory and critical care medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kristin R V HarringtonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: kristin.harrington@emory.edu.
Neel R GandhiDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Division of Infectious Diseases, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA, USA.
N Sarita ShahDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Division of Infectious Diseases, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA, USA.
Kogieleum NaidooCentre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC)-CAPRISA-TB-HIV Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal, Durban, South Africa; National Health Laboratory Service, Durban, South Africa.
Sara C AuldDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA, USA.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
James C M BrustDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, NY, USA.
Keeren LutchminarainNational Health Laboratory Service, Durban, South Africa; Department of Medical Microbiology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Megan CoeDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Fay WillisDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Angie CampbellDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Ted CohenDepartment of Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, USA.
Samuel M JennessDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Lance A WallerDepartment of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
CONTEXT Study Investigators

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI KIM, MIMI Y · 2003 to 2013
$18.6M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi, Jyothi Rengarajan · 2022 to 2026
$5.8M
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network StudyR01AI138646 · NIAID · EMORY UNIVERSITY · PI NAIDOO, KOGIELEUM, SHAH, NIPPIE SARITA · 2018 to 2022
$3.8M
EpiModel 2.0: Integrated Network Models for HIV/STI Prevention ScienceR01AI138783 · NIAID · EMORY UNIVERSITY · PI JENNESS, SAMUEL · 2018 to 2021
$3.0M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
Mentoring of multidisciplinary global health research in tuberculosis and HIVK24AI155045 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BRUST, JAMES C M · 2020 to 2025
$889k
Investigating Transmission Risk and Incidence of Extensively Drug-Resistant Tuberculosis in South AfricaF30AI152342 · NIAID · EMORY UNIVERSITY · PI HARRINGTON, KRISTIN R. · 2020 to 2023
$206k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS F30 AI152342NIAID NIH HHS K24 AI114444NIAID NIH HHS K24 AI155045NIAID NIH HHS P30 AI051519NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI138646NIAID NIH HHS R01 AI138783
6 · The paper itself

Abstract

purposeWe sought to understand the impact of the initial COVID-19 mitigation strategies in 2020 on drug-resistant (DR) TB diagnoses in KwaZulu-Natal province (KZN), South Africa.

methodsWe compared the number, spatial distribution, and characteristics of DR TB diagnoses before and after the initial COVID-19 lockdown on March 26th, 2020. Information on DR TB diagnoses was collected from the CONTEXT prospective cohort study and municipality characteristics were collected from Statistics South Africa. We used Bayesian conditional autoregressive models and relative-risk surface maps to examine spatial correlates and patterns of DR TB notifications.

resultsBetween October 2018 and February 2022, there were 693 individuals diagnosed with DR TB in KZN, South Africa. The rate of diagnoses per year was 274 and 155 prior and after to the initial lockdowns, respectively, corresponding to a 43 % decrease in the notification rate of cases. Compared to cases diagnosed before the lockdown, cases diagnosed after were less likely to have a fuel source for heating, piped water, a flush toilet, or own a phone (p-values≤0.02). Changes in notifications were not homogenously distributed, with predominantly rural northeastern and southwestern municipalities having significantly greater relative-risks after the lockdown.

conclusionsWe found a reduction in the rate of DR TB diagnoses after the COVID-19 pandemic lockdowns and observed that individuals diagnosed after the lockdowns had worse living conditions, fewer household resources, and more adults living in their household compared to before the pandemic.

Indexed as

COVID-19SARS-CoV-2Spatial AnalysisTuberculosis, Multidrug-ResistantAdolescentAdultBayes TheoremCommunicable Disease ControlFemaleHumansMaleMiddle AgedPandemicsProspective StudiesQuarantineSouth AfricaCOVID-19Drug-resistant TBSpatial analysisTuberculosis

Identifiers

PMID39038747
PMCPMC11408097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.